+41 41 399 18 00
CorFlow Therapeutics AG
Neuhofstrasse 3d 6340 Baar, Switzerland
CorFlow is developing a medical device that will be the first to diagnose MVO in real-time during PCI and serve as a treatment platform in the cath lab.
The CoFI-System is not approved in the United States of America. It is an investigational device limited by federal law to investigational use and is not available for commercial distribution.
VAT:CHE 320.873.257 MWST
© 2023 Corflow. All Rights Reserved.